300003 乐普医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.3768.08516.55716.10920.760
总资产报酬率 ROA (%)2.7715.0839.7558.85010.574
投入资产回报率 ROIC (%)3.1875.97311.46310.19911.615

边际利润分析
销售毛利率 (%)64.30564.24462.45561.00666.987
营业利润率 (%)23.70019.38924.72520.11926.735
息税前利润/营业总收入 (%)23.94520.54425.49021.74530.726
净利润/营业总收入 (%)20.39116.19521.17016.70223.351

收益指标分析
经营活动净收益/利润总额(%)100.173104.536102.715114.25583.790
价值变动净收益/利润总额(%)-1.559-0.865-2.715-17.12613.528
营业外收支净额/利润总额(%)-0.7460.469-0.4350.0722.457

偿债能力分析
流动比率 (X)2.7442.4812.0192.4451.367
速动比率 (X)2.0691.8721.5931.8631.071
资产负债率 (%)31.05530.07233.13540.70441.965
带息债务/全部投入资本 (%)25.70222.68823.82028.914--
股东权益/带息债务 (%)278.033327.178308.570222.404178.605
股东权益/负债合计 (%)202.285212.313186.701136.186129.574
利息保障倍数 (X)56.85019.30429.21213.4959.262

营运能力分析
应收账款周转天数 (天)101.80582.59860.56463.5180.000
存货周转天数 (天)339.386287.420190.043145.6180.000